Nasdaq

Harvard Apparatus Regenerative Technology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Establish a Research Collaboration to Study the ...

Holliston, MA, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage ...
News Medical

Driving innovation in regenerative medicine: €37.5 million grant for DRIVE-RM consortium

The DRIVE-RM consortium, led by Professor of Experimental Nephrology Marianne Verhaar from UMC Utrecht, has been awarded €37.5 million under the prestigious NWO SUMMIT program. The SUMMIT grant ...
Nasdaq

Instinct Brothers Co., Ltd, a Japanese Vertically Integrated Regenerative Medicine & Stem Cell Technology Company, to Go Public via Merger with Relativity Acquisition Corp.

NEW YORK, NY, TOKYO, JAPAN, March 04, 2025 (GLOBE NEWSWIRE) -- Instinct Brothers Co., Ltd., along with its affiliated entities—Hiroki Global Co., Ltd, Artisans ...
Los Angeles Times

Regenerative Medicine: A Deep Dive into Benefits, Risks, and Future Applications

Regenerative medicine combines tissue engineering and cell therapies to repair or replace damaged human tissues and organs. Key applications include treating osteoarthritis with mesenchymal stem cells ...